MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals: 3 sponsored US clinical trials, none currently recruiting.
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Idiopathic Parkinson´s Disease, with 1 trials.
Upper-quartile sponsor footprint
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Infusion of Apomorphine: Long-term Safety Study
NCT02339064
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
NCT02549573
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
NCT01770145
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
How the MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals archive is shaped
3 indexed studies, none listed as recruiting (0% open); 1 completed (33%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Idiopathic Parkinson´s Disease (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals page
3 registered trials is a research-attention snapshot, not an endorsement of MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals or any single study.
- None of MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Idiopathic Parkinson´s Disease is the condition MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Idiopathic Parkinson´s Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.